{"transactions":[{"id":4621412,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-09-17T20:30:11.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested"}],"balance_after":103077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-26-394394","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000119312526394394/ownership.xml","form_type":"4"}},{"id":4621411,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-17T20:30:11.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":72.98,"value":72980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.54 to $73.52 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-394394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000119312526394394/ownership.xml","form_type":"4"}},{"id":4621410,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-17T20:30:11.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001193125-26-394394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000119312526394394/ownership.xml","form_type":"4"}},{"id":683181,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-08-18T20:30:08.000Z","date":"2026-08-14","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":104077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-26-355561","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526355561/ownership.xml","form_type":"4"}},{"id":683180,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-18T20:30:08.000Z","date":"2026-08-14","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":74.54,"value":74540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-355561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526355561/ownership.xml","form_type":"4"}},{"id":683179,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-18T20:30:08.000Z","date":"2026-08-14","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001193125-26-355561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526355561/ownership.xml","form_type":"4"}},{"id":706647,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-07-17T20:15:02.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":105077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-26-307838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526307838/ownership.xml","form_type":"4"}},{"id":706646,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-17T20:15:02.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":71.17,"value":71170.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-307838","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526307838/ownership.xml","form_type":"4"}},{"id":706645,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-17T20:15:02.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001193125-26-307838","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526307838/ownership.xml","form_type":"4"}},{"id":726278,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-25T20:30:02.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":106077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-26-282861","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526282861/ownership.xml","form_type":"4"}},{"id":726277,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-25T20:30:02.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":70,"value":350000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-282861","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526282861/ownership.xml","form_type":"4"}},{"id":726276,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-25T20:30:02.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":0.6,"value":3000.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001193125-26-282861","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526282861/ownership.xml","form_type":"4"}},{"id":728774,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-23T20:30:16.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":111077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-26-279543","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526279543/ownership.xml","form_type":"4"}},{"id":728773,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:30:16.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":65,"value":325000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-279543","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526279543/ownership.xml","form_type":"4"}},{"id":728772,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:30:16.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":0.6,"value":3000.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001193125-26-279543","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526279543/ownership.xml","form_type":"4"}},{"id":739488,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:38:49.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":13980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":13980,"derivative":{"exercise_price":26.82,"expiration_date":"2036-06-10","underlying":"Ordinary Shares","underlying_shares":13980},"source":{"system":"sec-edgar","filing":"0000904454-26-000344","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445426000344/edgar.xml","form_type":"4"}},{"id":739487,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-12T21:38:49.000Z","date":"2026-06-11","kind":"sale","planned":false,"acquired":false,"shares":1993,"price":27.06,"value":53930.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":35494,"source":{"system":"sec-edgar","filing":"0000904454-26-000344","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445426000344/edgar.xml","form_type":"4"}},{"id":739486,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-12T21:38:49.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":7550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":37487,"source":{"system":"sec-edgar","filing":"0000904454-26-000344","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445426000344/edgar.xml","form_type":"4"}},{"id":747714,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-05T20:30:07.000Z","date":"2026-06-04","kind":"grant","planned":true,"acquired":true,"shares":9354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following June 4, 2026, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":9354,"derivative":{"exercise_price":56.09,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":9354},"source":{"system":"sec-edgar","filing":"0001193125-26-259705","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526259705/ownership.xml","form_type":"4"}},{"id":747713,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-05T20:30:07.000Z","date":"2026-06-04","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":116077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-26-259705","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526259705/ownership.xml","form_type":"4"}},{"id":747712,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:30:07.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":54.5,"value":54500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-259705","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526259705/ownership.xml","form_type":"4"}},{"id":747711,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:30:07.000Z","date":"2026-06-04","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026"}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001193125-26-259705","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526259705/ownership.xml","form_type":"4"}},{"id":995446,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-11-18T21:30:09.000Z","date":"2025-11-17","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":117077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-25-286228","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525286228/ownership.xml","form_type":"4"}},{"id":995445,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T21:30:09.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":41.43,"value":41430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-286228","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525286228/ownership.xml","form_type":"4"}},{"id":995444,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T21:30:09.000Z","date":"2025-11-17","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001193125-25-286228","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525286228/ownership.xml","form_type":"4"}},{"id":1018324,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-10-15T20:15:03.000Z","date":"2025-10-13","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":118077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-25-240271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525240271/ownership.xml","form_type":"4"}},{"id":1018323,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-15T20:15:03.000Z","date":"2025-10-13","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":43.25,"value":43250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-240271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525240271/ownership.xml","form_type":"4"}},{"id":1018322,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-15T20:15:03.000Z","date":"2025-10-13","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001193125-25-240271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525240271/ownership.xml","form_type":"4"}},{"id":1029164,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-10-01T21:07:18.000Z","date":"2025-09-30","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested"}],"balance_after":119077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-25-226964","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525226964/ownership.xml","form_type":"4"}},{"id":1029163,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-01T21:07:18.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":40.09,"value":200450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $40.00 to $40.20, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-226964","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525226964/ownership.xml","form_type":"4"}},{"id":1029162,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-01T21:07:18.000Z","date":"2025-09-30","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":0.6,"value":3000.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001193125-25-226964","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525226964/ownership.xml","form_type":"4"}},{"id":1039148,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-09-16T20:15:03.000Z","date":"2025-09-15","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":124077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-25-205003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525205003/ownership.xml","form_type":"4"}},{"id":1039147,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-16T20:15:03.000Z","date":"2025-09-15","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":35.1,"value":35100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-205003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525205003/ownership.xml","form_type":"4"}},{"id":1039146,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-16T20:15:03.000Z","date":"2025-09-15","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001193125-25-205003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525205003/ownership.xml","form_type":"4"}},{"id":1047706,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-09-04T20:30:05.000Z","date":"2025-09-03","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":125077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001235862-25-000003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000123586225000003/ownership.xml","form_type":"4"}},{"id":1047705,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T20:30:05.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":28,"value":28000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001235862-25-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000123586225000003/ownership.xml","form_type":"4"}},{"id":1047704,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T20:30:05.000Z","date":"2025-09-03","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001235862-25-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000123586225000003/ownership.xml","form_type":"4"}},{"id":1084594,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-07-18T20:30:05.000Z","date":"2025-07-17","kind":"exercise","planned":true,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":126077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000950170-25-096949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025096949/ownership.xml","form_type":"4"}},{"id":1084593,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-18T20:30:05.000Z","date":"2025-07-17","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":28,"value":56000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-096949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025096949/ownership.xml","form_type":"4"}},{"id":1084592,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-18T20:30:05.000Z","date":"2025-07-17","kind":"exercise","planned":true,"acquired":true,"shares":2000,"price":0.6,"value":1200.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0000950170-25-096949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025096949/ownership.xml","form_type":"4"}},{"id":1102546,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-24T22:03:58.000Z","date":"2025-06-20","kind":"sale","planned":false,"acquired":false,"shares":2112,"price":14.45,"value":30518.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.40 to $14.50. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":29937,"source":{"system":"sec-edgar","filing":"0000904454-25-000338","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445425000338/edgar.xml","form_type":"4"}},{"id":1111305,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T21:07:11.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":15630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":15630,"derivative":{"exercise_price":16.22,"expiration_date":"2035-06-11","underlying":"Ordinary Shares","underlying_shares":15630},"source":{"system":"sec-edgar","filing":"0000904454-25-000318","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445425000318/edgar.xml","form_type":"4"}},{"id":1111304,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-13T21:07:11.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":7970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":32049,"source":{"system":"sec-edgar","filing":"0000904454-25-000318","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445425000318/edgar.xml","form_type":"4"}},{"id":1119387,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-06T21:00:40.000Z","date":"2025-06-05","kind":"grant","planned":true,"acquired":true,"shares":24165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following June 5, 2025, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":24165,"derivative":{"exercise_price":26.63,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":24165},"source":{"system":"sec-edgar","filing":"0000950170-25-083240","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025083240/ownership.xml","form_type":"4"}},{"id":1136861,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-22T20:15:05.000Z","date":"2025-05-21","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":128077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-25-076339","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025076339/ownership.xml","form_type":"4"}},{"id":1136860,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T20:15:05.000Z","date":"2025-05-21","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":28,"value":28000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-076339","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025076339/ownership.xml","form_type":"4"}},{"id":1136859,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T20:15:05.000Z","date":"2025-05-21","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000950170-25-076339","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025076339/ownership.xml","form_type":"4"}},{"id":1163830,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-04-29T20:15:03.000Z","date":"2025-04-28","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":129077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-25-060145","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025060145/ownership.xml","form_type":"4"}},{"id":1163829,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-29T20:15:03.000Z","date":"2025-04-28","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":30.76,"value":30760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-060145","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025060145/ownership.xml","form_type":"4"}},{"id":1163828,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-29T20:15:03.000Z","date":"2025-04-28","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000950170-25-060145","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025060145/ownership.xml","form_type":"4"}},{"id":1199230,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-03-18T20:30:26.000Z","date":"2025-03-17","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":130077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-25-041265","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025041265/ownership.xml","form_type":"4"}},{"id":1199229,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-18T20:30:26.000Z","date":"2025-03-17","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":28,"value":28000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-041265","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025041265/ownership.xml","form_type":"4"}},{"id":1199228,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-18T20:30:26.000Z","date":"2025-03-17","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000950170-25-041265","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025041265/ownership.xml","form_type":"4"}},{"id":1259235,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-02-19T21:15:05.000Z","date":"2025-02-18","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":131077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-25-023182","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025023182/ownership.xml","form_type":"4"}},{"id":1259234,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-19T21:15:05.000Z","date":"2025-02-18","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":28.61,"value":28610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-023182","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025023182/ownership.xml","form_type":"4"}},{"id":1259233,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-19T21:15:05.000Z","date":"2025-02-18","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000950170-25-023182","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025023182/ownership.xml","form_type":"4"}},{"id":1303280,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-01-14T21:16:52.000Z","date":"2025-01-13","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":132077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-25-005359","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025005359/ownership.xml","form_type":"4"}},{"id":1303279,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-14T21:16:52.000Z","date":"2025-01-13","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":29.66,"value":29660.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-005359","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025005359/ownership.xml","form_type":"4"}},{"id":1303278,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-14T21:16:52.000Z","date":"2025-01-13","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000950170-25-005359","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025005359/ownership.xml","form_type":"4"}},{"id":1328331,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-12-17T22:00:11.000Z","date":"2024-12-16","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":133077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-24-137319","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017024137319/ownership.xml","form_type":"4"}},{"id":1328330,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-17T22:00:11.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":28.84,"value":28840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-137319","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017024137319/ownership.xml","form_type":"4"}},{"id":1328329,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-17T22:00:11.000Z","date":"2024-12-16","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000950170-24-137319","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017024137319/ownership.xml","form_type":"4"}},{"id":1340257,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-12-06T23:51:46.000Z","date":"2024-12-06","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":134077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-24-134261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017024134261/ownership.xml","form_type":"4"}},{"id":1340256,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-06T23:51:46.000Z","date":"2024-12-06","kind":"sale","planned":true,"acquired":false,"shares":250,"price":34.976,"value":8744.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $34.92 to $35.05. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-134261","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017024134261/ownership.xml","form_type":"4"}},{"id":1340255,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-06T23:51:46.000Z","date":"2024-12-06","kind":"sale","planned":true,"acquired":false,"shares":750,"price":34.3973,"value":25797.975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $33.91 to $34.87. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":250,"source":{"system":"sec-edgar","filing":"0000950170-24-134261","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017024134261/ownership.xml","form_type":"4"}},{"id":1340254,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-06T23:51:46.000Z","date":"2024-12-06","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0000950170-24-134261","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017024134261/ownership.xml","form_type":"4"}},{"id":1389980,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-07T21:17:50.000Z","date":"2024-10-04","kind":"grant","planned":false,"acquired":true,"shares":15600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following October 4, 2024, the date of grant, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":15600,"derivative":{"exercise_price":36.63,"expiration_date":"2034-10-03","underlying":"Common Stock","underlying_shares":15600},"source":{"system":"sec-edgar","filing":"0000950170-24-113320","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017024113320/ownership.xml","form_type":"4"}},{"id":1471885,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:00:37.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":15840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":15840,"derivative":{"exercise_price":4.57,"expiration_date":"2034-06-19","underlying":"Ordinary Shares","underlying_shares":15840},"source":{"system":"sec-edgar","filing":"0000904454-24-000397","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445424000397/edgar.xml","form_type":"4"}},{"id":1471884,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-06-21T21:00:37.000Z","date":"2024-06-19","kind":"grant","planned":false,"acquired":true,"shares":8080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":24079,"source":{"system":"sec-edgar","filing":"0000904454-24-000397","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445424000397/edgar.xml","form_type":"4"}},{"id":1474975,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-06-18T22:11:03.000Z","date":"2024-06-13","kind":"sale","planned":false,"acquired":false,"shares":2222,"price":5.14,"value":11421.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.13 to $5.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":15999,"source":{"system":"sec-edgar","filing":"0000904454-24-000385","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445424000385/edgar.xml","form_type":"4"}},{"id":1849195,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-20T21:28:16.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":17060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":17060,"derivative":{"exercise_price":20.18,"expiration_date":"2033-06-13","underlying":"Ordinary Shares","underlying_shares":17060},"source":{"system":"sec-edgar","filing":"0000904454-23-000400","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445423000400/edgar.xml","form_type":"4"}},{"id":1849194,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-20T21:28:16.000Z","date":"2023-06-16","kind":"sale","planned":false,"acquired":false,"shares":2291,"price":18.83,"value":43139.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"shares","element":"transactionShares","label":"F3","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.81 to $18.94. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18221,"source":{"system":"sec-edgar","filing":"0000904454-23-000400","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445423000400/edgar.xml","form_type":"4"}},{"id":1849193,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-20T21:28:16.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":20512,"source":{"system":"sec-edgar","filing":"0000904454-23-000400","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445423000400/edgar.xml","form_type":"4"}},{"id":1983270,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-03-01T21:19:44.000Z","date":"2023-02-27","kind":"sale","acquired":false,"shares":389,"price":19.73,"value":7674.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"shares","element":"transactionShares","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. 386 of the shares were sold in multiple transactions at prices ranging from $19.66 to $19.97 and 3 of the shares were sold at $20.82. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":11812,"source":{"system":"sec-edgar","filing":"0000899243-23-006594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000089924323006594/doc4.xml","form_type":"4"}},{"id":2195813,"issuer":{"id":2545,"kind":"organization","name":"Fulgent Genetics, Inc.","symbol":"FLGT"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-03T21:44:13.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2022, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-22-044302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674930/000120919122044302/doc4.xml","form_type":"4"}},{"id":2227307,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T20:59:07.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":17810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":17810,"derivative":{"exercise_price":14.08,"expiration_date":"2032-06-15","underlying":"Ordinary Shares","underlying_shares":17810},"source":{"system":"sec-edgar","filing":"0000904454-22-000362","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445422000362/edgar.xml","form_type":"4"}},{"id":2227306,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-06-17T20:59:07.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":9080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":12201,"source":{"system":"sec-edgar","filing":"0000904454-22-000362","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445422000362/edgar.xml","form_type":"4"}},{"id":2360016,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-03-02T22:45:57.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":795,"price":16.64,"value":13228.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"shares","element":"transactionShares","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $16.64 to $16.80.  The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3121,"source":{"system":"sec-edgar","filing":"0000904454-22-000221","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445422000221/edgar.xml","form_type":"4"}},{"id":2368605,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-28T23:43:58.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":2645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":2645,"derivative":{"exercise_price":16.04,"expiration_date":"2032-02-24","underlying":"Ordinary Shares","underlying_shares":2645},"source":{"system":"sec-edgar","filing":"0000904454-22-000199","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445422000199/edgar.xml","form_type":"4"}},{"id":2368604,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-02-28T23:43:58.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":1534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated.  Each restricted share unit represents the contingent right to receive one Ordinary Share.  The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":3916,"source":{"system":"sec-edgar","filing":"0000904454-22-000199","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445422000199/edgar.xml","form_type":"4"}},{"id":2825861,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-01T21:30:38.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":4107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":4107,"derivative":{"exercise_price":37,"expiration_date":"2031-02-25","underlying":"Ordinary Shares","underlying_shares":4107},"source":{"system":"sec-edgar","filing":"0000904454-21-000265","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445421000265/edgar.xml","form_type":"4"}},{"id":2825860,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-03-01T21:30:38.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":2382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated.  Each restricted share unit represents the contingent right to receive one Ordinary Share.  The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date."}],"balance_after":2382,"source":{"system":"sec-edgar","filing":"0000904454-21-000265","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445421000265/edgar.xml","form_type":"4"}},{"id":3028003,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (Right to Buy)","published_at":"2020-09-17T16:28:23.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option vests over three years, with 33.33% vesting after twelve months from the date of grant and then 8.33% every three months thereafter, subject to the Reporting Person's continued relationship with the Issuer through each such date."}],"balance_after":10000,"derivative":{"exercise_price":38.67,"expiration_date":"2030-09-15","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000904454-20-000614","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000090445420000614/edgar.xml","form_type":"4"}}]}